Neurovascular Devices Market worth $7.22 billion in 2030

Browse 150 market data Tables and 70 Figures spread through 300 Pages and in-depth TOC on "Neurovascular Devices Market by Disease Pathology (Cerebral Aneurysm (Embolic coils, Flow Diverters), Ischemic Stroke (Clot Retriever, Aspiration, Snare), Carotid Stenosis (Stent, Embolic Protection), Others), End User (Hospitals) - Global Forecast to 2030
The global Neurovascular Devices Market [https://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulation-devices-market-847.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=neurovasculardevicesmarket], valued at US$4.27 billion in 2024, stood at US$4.64 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$7.22 billion by the end of the period. Several factors influence the neurovascular devices market. The two most significant ones are the rising incidence of neurovascular diseases and the expansion of healthcare infrastructure across emerging economies, which are key drivers for the neurovascular devices market. The increasing prevalence of conditions such as stroke, cerebral aneurysms, and arteriovenous malformations is largely due to aging populations, sedentary lifestyles, poor dietary habits, rising rates of hypertension and diabetes, and increased exposure to risk factors like smoking and alcohol consumption. As these diseases often require urgent and specialized interventions, the demand for advanced neurovascular devices such as thrombectomy systems, embolization coils, and flow diverters continues to grow.

Certain challenges may, however, impede market expansion. The high procedural costs of neurovascular surgeries and related products pose a major barrier, as many patients-especially in low- and middle-income regions-cannot afford advanced technologies. Additionally, stringent regulatory approval processes for medical devices further slowdown the market penetration.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=neurovasculardevicesmarket]

By disease pathology, the global neurovascular devices market is divided into five main segments: cerebral aneurysms, ischemic strokes, carotid artery stenosis, arteriovenous malformations and fistulas, and other disease pathologies.

The high incidence of cerebral aneurysms results from a combination of genetic, physiological, and lifestyle factors. People with a family history or certain genetic disorders are more vulnerable, while chronic hypertension, smoking, and atherosclerosis further weaken blood vessel walls. Age and gender also influence risk, with middle-aged adults and women being more susceptible. Additionally, lifestyle choices like alcohol abuse and sedentary behaviors add to vascular stress, collectively increasing the likelihood of aneurysm formation.

By end user, the global neurovascular devices market is segmented by end user into the following categories: hospitals & ambulatory surgical centers, specialty clinics, research and academic institutes.

Among these, the hospitals & ambulatory surgical centers segment is expected to hold the largest market share because they provide the necessary infrastructure, specialized equipment, and trained personnel needed for complex neurovascular procedures. These facilities can manage high-risk cases such as strokes, cerebral aneurysms, and arteriovenous malformations, which often require immediate intervention. Advanced imaging technologies, operating rooms designed for minimally invasive surgeries, and multidisciplinary teams make hospitals and surgical centers the preferred settings for neurovascular treatments. Additionally, their ability to handle post-operative care and emergencies further strengthens their dominant role in the market.

By geography, The global market for neurovascular devices is divided into six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries.

North America leads the neurovascular devices market, supported by a robust healthcare infrastructure and high consumer demand for neurovascular devices. The region has a well-developed healthcare system with widespread access to advanced hospitals, specialized surgical centers, and skilled neurosurgeons. The high prevalence of neurological conditions such as stroke, cerebral aneurysms, and other vascular disorders fuels strong demand for neurovascular devices. Additionally, North America is an early adopter of innovative technologies, including minimally invasive devices, AI-assisted imaging, and robot-guided procedures, which enhance the use of advanced neurovascular solutions. Supportive government healthcare policies, insurance coverage, and high patient awareness also contribute to the region's dominant market position.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=847 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=847&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=neurovasculardevicesmarket]

Prominent players in the neurovascular devices market include Stryker (US), Medtronic (Ireland), Johnson & Johnson (US), Terumo Corporation (Japan), Penumbra (US), MicroPort Scientific Corporation (China), Balt Group (France), Kaneka Corporation (Japan), and Phenox GmbH (Wallaby Medical). Among other developments, these companies adopted strategies such as partnerships, collaborations, agreements, integrations, acquisitions, product launches, and expansions to strengthen their presence in the neurovascular devices market.

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=neurovascular-devices-market-worth-722-billion-in-2030]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulation-devices-market-847.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.